MCM
CGEM icon

MAI Capital Management’s Cullinan Oncology CGEM Stock Holding History

MAI Capital Management’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-938
Closed -$13.3K – 2529
2026
Q1 		$13.3K Buy
938
+920
+5,111% +$11.8K ﹤0.01% 3001
2025
Q4 		$187 Buy
+18
New +$162 ﹤0.01% 4060
2025
Q3 		– Sell
-76
Closed -$573 – 3871
2025
Q2 		$573 Buy
+76
New +$611 ﹤0.01% 3744

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

MAI Capital Management's CGEM Position: Q2 2026 in Review

MAI Capital Management sold out of Cullinan Oncology (CGEM) in Q2 2026, closing a stake of 938 shares — an estimated $13.3K sold.

MAI Capital Management first reported a position in CGEM in Q2 2025 and held it in 3 quarters. The position peaked at $13.3K in Q1 2026. 183 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • MAI Capital Management reported no remaining Cullinan Oncology position as of Q2 2026 after selling out during the quarter.
  • MAI Capital Management sold 938 Cullinan Oncology shares in Q2 2026, an estimated $13.3K.
  • MAI Capital Management first reported a position in Cullinan Oncology in Q2 2025 and held it in 3 quarters.
  • MAI Capital Management's Cullinan Oncology position peaked at $13.3K in Q1 2026.
  • 183 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.